Pathology Billing — Technical vs Professional, Specimen Coding & Every Complex Claim Paid

Pathology billing operates under the same technical vs professional component framework as radiology — but with the added complexity of specimen-based coding where the number, type, and source of specimens determine every code, molecular pathology with its own tiered code set, immunohistochemistry with per-stain billing, and a regulatory environment (CLIA certification, anti-markup rules) that directly affects what pathology practices can bill and how. Netix handles every layer so your pathologists interpret specimens while we make sure every laboratory service gets paid correctly.

Get a Free Pathology Billing Audit

See How It Works

Technical vs professional component billing specialists

Specimen-based code selection by type and source

Molecular pathology tiered billing expertise

THE PROBLEM

Why Pathology Practices Lose Revenue Across Every Service Category

Pathology billing errors are specimen documentation errors and component billing errors — the correct code depends on what tissue was submitted, how many specimens were received, what testing was performed, and which component of the service the pathologist is billing. Here is where the losses happen most consistently

Technical vs professional component billing is as critical in pathology as in radiology — and equally misapplied.

Pathology services have two components — the technical component (TC: laboratory processing, staining, slide preparation, equipment) and the professional component (modifier 26: pathologist’s microscopic examination and interpretation). When a pathologist works in a hospital-owned laboratory, typically only the professional component (modifier 26) is billed by the pathologist — the hospital bills the technical component. When a pathologist owns an independent laboratory, the global service is billed. Billing global when only interpretation was performed creates serious overbilling and compliance exposure. Missing the professional component modifier 26 when interpreting hospital specimens loses the interpretation revenue on every specimen read.

Specimen counting errors are the most common billing error in surgical pathology.

Surgical pathology codes (88300–88309) are selected based on the level of complexity of the specimen — not based on what diagnosis was found. The code level is determined by the specimen type submitted. When multiple specimens are submitted from the same surgical case, each separately submitted specimen is billed separately — multiple tissue types from the same patient submitted in separate containers each generate a separate pathology code. Most pathology practices either bill a single specimen code regardless of how many specimens were submitted, apply the wrong level code for the specimen type, or fail to count separately submitted specimens from the same patient correctly.

Surgical pathology level selection errors result in systematic undercoding or compliance exposure.

Surgical pathology codes range from Level I (88300 — gross examination only, e.g., foreign body) through Level VI (88309 — complex specimens, e.g., radical resections). The level is determined by the specimen type per CPT guidelines — not by the pathologist’s subjective assessment of difficulty. Most pathology practices either apply a single code level regardless of specimen type or ucode complex specimens without documentation that supports the complexity level billed.

Immunohistochemistry billing is routinely incomplete.

Immunohistochemical stains (88342 first stain, 88341 each additional stain, 88344 multiplexed antibody stain) — each stain applied to a specimen is separately billable. Most pathology practices either bill a single IHC code regardless of how many stains were applied, miss the add-on codes for additional stains, or fail to document each stain applied in the pathology report to support the number of codes billed.

Molecular pathology billing is the most complex billing in the specialty — and the most consistently under-coded.

Molecular pathology codes (81161–81408 by analyte and test complexity tier, Tier 1 for specific named tests and Tier 2 for less common analytes by complexity level) — the correct code depends on the specific gene or analyte tested, the methodology used, and whether the test is Tier 1 (named gene-specific code) or Tier 2 (complexity-based code). Most pathology practices either apply generic molecular pathology codes regardless of the specific analyte tested, apply Tier 2 codes when a named Tier 1 code exists (underbilling), or miss add-on codes for additional analytes tested on the same specimen.

Anti-markup rules affect pathology billing when specimens are referred out — and most practices handle them incorrectly.

When a pathology practice refers specimens to an outside laboratory for testing and then bills the patient or payer for those outside tests, anti-markup rules apply — the practice cannot mark up the outside laboratory’s charge. Most pathology practices either unknowingly violate anti-markup rules or overcorrect by not billing referred testing at all, when they may legitimately bill the professional interpretation component.

OUR PATHOLOGY BILLING SERVICES

What Netix Handles for Pathology Practices

Technical vs Professional Component Billing

Correct component billing on every pathology service — global billing (no modifier) when the pathologist owns the laboratory and performs the interpretation, modifier 26 (professional component only) when interpreting specimens processed by a hospital or independent laboratory owned by another entity, and modifier TC when billing the laboratory processing component separately — with pre-submission verification of the correct billing scenario per laboratory site.

Surgical Pathology Billing

Correct level code selection (88300–88309) for every specimen type submitted — with specimen-by-specimen level assignment per CPT specimen type guidelines, separate code for each separately submitted container from the same patient, and documentation review confirming the pathology report supports the level billed.

Cytopathology Billing

Cervical cytology (88141–88155, G0123–G0124 for Medicare Pap smears), non-gynecological cytology (88160–88162), and fine needle aspiration cytology (88172–88173) — correct code selection by specimen type, preparation method, and interpretation complexity.

Immunohistochemistry Billing

First stain (88342), each additional single antibody stain (88341), and multiplexed antibody stain (88344) — stain-by-stain billing with each antibody applied documented in the pathology report, correct first vs additional stain distinction, and quantitative IHC (88360) or in-situ hybridization (88365–88368) where applicable.

Molecular Pathology Billing

Tier 1 molecular pathology (81161–81383 — specific named gene tests) and Tier 2 molecular pathology (81400–81408 by complexity level) — correct tier assignment based on the specific analyte and test performed, named gene code selection when a Tier 1 code exists for the specific test, and add-on code billing for additional analytes tested on the same specimen.

FISH and In-Situ Hybridization Billing

Fluorescence in-situ hybridization (88365–88368) — correct probe type (single, dual, multiple) and specimen type billing, with prior auth management for oncology FISH panels that payers require authorization for.

Hematopathology Billing

Bone marrow biopsy interpretation (85097 smear with interpretation, G0364 add-on), lymph node biopsy interpretation, and flow cytometry (88184 first marker, 88185 each additional marker) — correct marker count billing with each antibody tested documented in the flow cytometry report.

Autopsy Billing

Gross and microscopic autopsy (88020–88037 by extent and type) — hospital autopsy vs forensic autopsy billing distinction, and professional interpretation billing separate from facility autopsy services.

Clinical Laboratory Billing

Complete blood count (85025), comprehensive metabolic panel (80053), lipid panel (80061), urinalysis (81001), blood culture (87040), and other clinical laboratory tests — panel billing rules applied correctly (individual tests within a panel are not separately billed when the panel code covers them), and PAMA pricing compliance for Medicare clinical laboratory billing.

Special Stains Billing

Special stains (88312 per stain group one, 88313 per stain group two) — stain group classification per CPT guidelines, correct group assignment, and per-stain billing with stain documentation in the pathology report.

Anti-Markup Rule Compliance

Referred specimen billing in compliance with anti-markup rules — billing only what the practice is entitled to bill for referred testing, professional interpretation billing where the pathologist actually interpreted referred specimens, and documentation of the interpretation to support the professional component claim.

Prior Authorization Management

Molecular pathology panels for oncology, hereditary cancer testing (BRCA, Lynch syndrome), pharmacogenomics testing, and certain advanced pathology techniques — auth obtained with clinical indication documentation, ordering physician information, and specific test justification per payer requirements.

Denial Management — Pathology Specific

Specimen level disputes, TC/26 modifier challenges, IHC stain count denials, molecular pathology tier disputes, anti-markup compliance challenges, and medical necessity denials on advanced testing — appealed with pathology report documentation and CPT specimen type guideline evidence.

SURGICAL PATHOLOGY LEVEL CODING EXPLAINED

Surgical Pathology Level Coding — Specimen Type Determines the Code

Surgical pathology level coding is the most specimen-specific billing in all of medicine — the correct code is determined by the type of tissue submitted, not by the diagnosis found or the complexity of the pathologist’s interpretation.

The six surgical pathology levels:

Level I — 88300 (Gross examination only):
Specimens examined macroscopically without microscopic sections.
Examples: Foreign body, gallstones, calculi, teeth, placental membrane (in some cases)
Base unit: lowest reimbursement

Level II — 88302 (Gross and microscopic, simple):
Specimens requiring gross and microscopic examination for uncomplicated diagnosis.
Examples: Appendix (incidental), fallopian tube for sterilization, finger/toe amputation for non-tumor causes, foreskin for circumcision, hernia sac, nerve, skin (plastic repair)

Level III — 88304 (Gross and microscopic, intermediate):
Specimens with somewhat greater complexity.
Examples: Abortion (induced), bone fragments, cataract, cervix biopsy (punch), lipoma, lymph node biopsy (incidental), polyp (colorectal), skin biopsy, small intestine (not for tumor), soft tissue (not for tumor), tendon, ureter

Level IV — 88305 (Gross and microscopic, moderate complexity):
The most commonly billed level — moderate complexity specimens.
Examples: Bone marrow biopsy (trephine), breast biopsy (not requiring frozen section), bronchus biopsy, colon/rectum biopsy, esophagus biopsy, fallopian tube (not for sterilization), kidney biopsy, liver biopsy, lung biopsy, lymph node biopsy, ovary with or without tube (non-tumor), prostate biopsy, thyroid biopsy, uterine curettings

Level V — 88307 (Gross and microscopic, high complexity):
Complex specimens requiring extensive examination.
Examples: Bladder (resection not for tumor), bone marrow biopsy (additional sections), brain/meninges biopsy, breast (mastectomy for gynecomastia), colon/rectum (resection for non-tumor), kidney (nephrectomy for non-tumor), larynx/pharynx biopsy, ovary with or without tube (tumor), placenta (not third trimester), prostate (TURP), skin (extensive resection of malignancy), small intestine (resection for tumor), testis (tumor), thyroid (thyroidectomy for tumor)

Level VI — 88309 (Gross and microscopic, highest complexity):
The most complex specimens — radical resections and complex tumor specimens.
Examples: Bone (resection for tumor), colon/rectum (resection for tumor), kidney (nephrectomy for tumor), larynx (total laryngectomy), liver (resection for tumor), lung (lobectomy or pneumonectomy), pancreatectomy, radical prostatectomy, uterus with tubes and ovaries (for malignancy), Whipple resection

Multiple specimens — billing correctly:

When multiple specimens are submitted from the same surgical case in separate containers, each specimen is billed at its appropriate level:

Prostate biopsy (8 cores in 8 containers) = 88305 × 8
Endoscopy with biopsy from two anatomic sites (two containers) = 88305 × 2
Breast excision with sentinel lymph node (two containers) = 88305 (breast) + appropriate level for lymph node

What we do:

Specimen-by-specimen level assignment per CPT specimen type guidelines on every pathology case — correct level per specimen type, separate billing per container, and pathology report documentation review confirming the report supports the number of specimens and levels billed.

MOLECULAR PATHOLOGY BILLING

Molecular Pathology Billing — Tier 1 Named Tests vs Tier 2 Complexity Levels

Molecular pathology billing is the fastest-growing and most complex service category in pathology — and the one with the most consistent undercoding errors.

Two-tier molecular pathology code system:

Tier 1 — Named gene-specific codes (81161–81383):
Specific CPT codes for specific molecular tests on specific genes or analytes. When a named Tier 1 code exists for the test performed, that code must be used — not a generic Tier 2 code.

Examples of Tier 1 codes:

81211: BRCA1, BRCA2 (hereditary breast/ovarian cancer) sequencing
81215: BRCA1 known familial variant
81235: EGFR (lung cancer) gene analysis
81275: KRAS (colorectal/lung cancer) gene analysis
81313: PCA3/KLK3 (prostate cancer)
81321: PTEN (tumor suppressor) sequencing
81351: TP53 (tumor protein p53)
81374: HLA typing

Tier 2 — Complexity-based codes (81400–81408):
For molecular tests where no specific Tier 1 code exists, Tier 2 codes are used — selected based on the complexity of the analytical method used, not the specific analyte:

81400: Molecular pathology, Level 1 (simple)
81401: Level 2
81402: Level 3
81403: Level 4
81404: Level 5
81405: Level 6
81406: Level 7
81407: Level 8
81408: Level 9 (highest complexity)

The most common molecular pathology billing errors:

Using Tier 2 codes when a named Tier 1 code exists — this is both incorrect and typically underbills the service because Tier 1 codes for specific oncology tests often reimburse higher than a generic Tier 2 code. Most molecular pathology billing errors occur because the billing team does not know which specific test maps to which Tier 1 code and defaults to Tier 2.

Genomic sequencing panels:

Next-generation sequencing (NGS) panels have their own code set — 81445 (solid organ neoplasm, small panel), 81450 (hematolymphoid neoplasm, small panel), 81455 (solid organ neoplasm, large panel) — with documentation of genes analyzed in the panel report supporting the panel code billed.

Prior authorization for molecular pathology:

Hereditary cancer testing (BRCA, Lynch syndrome genes, APC), pharmacogenomics panels, and certain oncology molecular testing panels require prior auth from most commercial payers. Documentation must establish clinical indication — personal or family cancer history for hereditary testing, specific diagnosis for oncology panels, and prescribing decision support for pharmacogenomics.

What we do:

Test-specific Tier 1 code identification for every molecular test performed — Tier 2 used only when no Tier 1 code exists for the specific analyte tested, correct complexity level assignment for Tier 2 codes, genomic panel code selection, and prior auth management for hereditary and oncology molecular testing.

PATHOLOGY BILLING CODES WE KNOW COLD

Pathology CPT Codes — Handled by Specialists

CPT Code	Service	Common Issue
88300	Surgical pathology Level I gross only	Wrong level for specimen type
88302	Surgical pathology Level II	Specimen type determination errors
88304	Surgical pathology Level III	Level III vs Level IV confusion
88305	Surgical pathology Level IV	Most commonly billed — correct level?
88307	Surgical pathology Level V	Complex specimens undercoded
88309	Surgical pathology Level VI	Radical resection documentation
88342	IHC first antibody stain	Per-stain add-on billing missed
88341	IHC each additional antibody	Additional stains not separately billed
88344	IHC multiplexed antibody stain	Multiplex vs individual stain distinction
88360	Morphometric analysis IHC	Quantitative vs qualitative distinction
88365	In-situ hybridization first probe	FISH probe type and count
88366	ISH each additional probe	Add-on probes missed
88312	Special stains group one	Stain group classification errors
88313	Special stains group two	Wrong group assignment
88141	Cervical cytology interpretation	TC/26 split missed
88160	Non-gyn cytology simple	Preparation method code selection
88161	Non-gyn cytology comprehensive	Complexity level documentation
88172	FNA cytology evaluation	Rapid evaluation vs interpretation
88173	FNA cytology interpretation	Separate from 88172 billing
88184	Flow cytometry first marker	Marker count documentation
88185	Flow cytometry each additional	Add-on marker count
81211	BRCA1/2 sequencing	Tier 2 billed when Tier 1 exists
81235	EGFR gene analysis	Prior auth missed
81275	KRAS gene analysis	Tier 1 vs Tier 2 determination
81445	NGS small panel solid tumor	Panel size documentation
81455	NGS large panel solid tumor	Prior auth for NGS panels
85025	CBC with differential	Panel vs individual test bundling
80053	Comprehensive metabolic panel	PAMA pricing compliance

IMMUNOHISTOCHEMISTRY BILLING

Immunohistochemistry Billing — Every Stain, Every Antibody, Every Code

Immunohistochemistry is the highest-volume add-on service in surgical pathology — and the most consistently underbilled.

The IHC code structure:

88342: Immunohistochemistry or immunocytochemistry — first antibody stain per specimen
88341: Each additional single antibody stain per specimen (add-on)
88344: Multiplexed antibody stain (when multiple antibodies are applied simultaneously to detect colocalization)
88360: Morphometric analysis of cells using IHC (quantitative analysis)
88361: Morphometric analysis of tumors

The billing rule:
Each antibody applied to a specimen is a separately billable stain. A specimen receiving 5 IHC stains is billed as:

88342 × 1 (first stain)
88341 × 4 (each of the 4 additional stains)

The most common IHC billing errors:

Error 1 — Billing only 88342 regardless of stain count:
A pathology report documents 6 IHC stains applied — CK7, CK20, CDX2, TTF-1, p40, and CD56. The correct billing is 88342 × 1 + 88341 × 5. Most pathology practices bill only one unit of 88342 — losing 5 units of 88341 on every multi-stain case.

Error 2 — Missing documentation of each stain:
The pathology report must identify each antibody applied and its result. A report that says “IHC panel performed” without listing each antibody does not support per-stain billing. The documentation and the billing must match stain for stain.

Error 3 — Billing 88342 for restains:
When additional IHC stains are ordered on a specimen already billed with 88342, the additional stains are billed as 88341 (not as additional 88342 codes). Multiple 88342 codes for the same specimen in the same service period creates a billing error.

Oncology IHC panels:

ER/PR/HER2 panel for breast cancer, mismatch repair proteins (MLH1, MSH2, MSH6, PMS2) for Lynch syndrome screening, PD-L1 for immunotherapy eligibility — each antibody separately billed with the pathology report documenting each stain result.

What we do:

Stain-by-stain billing review on every IHC case — correct first stain vs additional stain code, stain count matched to pathology report documentation, multiplexed stain distinction where applicable, and pre-submission stain count verification.

Who We Serve

Pathology Providers We Work With

Hospital-based pathology groups

Modifier 26 professional component billing across anatomic and clinical pathology

Independent pathology laboratories

Global billing for owned laboratory with TC + professional component across all pathology services

Anatomic pathology practices

Surgical pathology, cytopathology, and autopsy billing with specimen-level coding

Academic pathology programs

Teaching physician billing rules, resident supervision, and academic billing compliance

Dermatopathology practices

Skin biopsy level coding, Mohs specimen interpretation billing, and dermatopathology subspecialty billing

Hematopathology practices

Bone marrow biopsy interpretation, flow cytometry billing, and lymph node pathology coding

Molecular pathology laboratories

Tier 1 and Tier 2 molecular code assignment, NGS panel billing, and hereditary testing prior auth management

Cytopathology practices

Gynecological and non-gynecological cytology billing, FNA interpretation billing, and liquid-based cytology coding

RESULTS WE BUILD TOWARD

What Pathology Billing Looks Like When It Works

First-pass clean claim rate: 96%+

Days in AR: under 28 (pathology AR should move efficiently — services are completed before billing, diagnosis is confirmed)

TC/26 modifier accuracy: zero errors — correct component per laboratory ownership on every claim

Surgical pathology level accuracy: 100% — correct level per CPT specimen type guidelines on every specimen

IHC stain count accuracy: 100% — every antibody documented in the report billed as a separate stain

Molecular pathology Tier 1 capture: named gene codes applied whenever a Tier 1 code exists for the test

Specimen count accuracy: all separately submitted containers billed as separate specimens

Monthly report: revenue per pathologist, per service category (surgical pathology vs cytology vs IHC vs molecular vs clinical lab), per payer

Numbers based on industry benchmarks — your practice-specific results reported monthly.

FAQ

Pathology Billing Questions

When should we bill modifier 26 vs the global service?

Modifier 26 (professional component only) applies when you interpret specimens processed by a hospital or laboratory that owns the equipment and handles the processing — the facility bills the TC and you bill only the interpretation. The global service (no modifier) applies when your pathology group owns the laboratory and performs both processing and interpretation. Billing global when only interpretation was performed is a serious compliance error with significant recoupment risk. The free audit reviews your current modifier assignment against your laboratory ownership and site of service arrangements.

How do we determine the correct surgical pathology level for each specimen?

The level is determined by the specimen type per CPT guidelines — not by diagnosis difficulty or pathologist time. Each specimen type is listed in CPT at a specific level. A prostate biopsy is always Level IV (88305) regardless of whether the interpretation is straightforward or complex. The CPT specimen type list is authoritative — we apply it to every specimen on every case. The audit includes a specimen type vs code level review on recent cases.

We perform IHC on most of our tumor cases. Are we billing all the stains?

Each antibody applied to a specimen is separately billable — 88342 for the first stain, 88341 for each additional. If your IHC cases consistently show only one or two billing units regardless of how many antibodies the pathology report documents, you are losing add-on stain revenue on every multi-stain case. The audit matches your IHC billing unit count against the stain count in your pathology reports.

How do we know if we should use Tier 1 or Tier 2 molecular pathology codes?

If a specific CPT code exists for the gene or analyte you tested (81161–81383), that Tier 1 code must be used — not a generic Tier 2 code. Tier 2 codes (81400–81408) apply only when no Tier 1 code exists for the specific analyte. The most common error is using Tier 2 for tests that have named Tier 1 codes — which is both incorrect and typically underbills the service. We maintain current Tier 1 code mapping for every molecular test and apply the correct code on every molecular pathology claim.

Can you handle prior authorization for molecular pathology testing?

Yes — hereditary cancer testing (BRCA, Lynch syndrome), pharmacogenomics panels, and oncology NGS panels require prior auth from most commercial payers. We assemble clinical indication documentation (personal cancer history, family history, specific diagnosis), ordering physician information, and test justification per payer requirements — and track auth to approval before testing is performed.

What makes pathology billing harder than general laboratory billing?

Specimen-based surgical pathology level coding (where the correct code depends on the specific tissue type submitted), immunohistochemistry per-stain billing with add-on codes for each antibody, molecular pathology Tier 1 vs Tier 2 determination requiring test-specific code knowledge, technical vs professional component splitting across multiple laboratory ownership arrangements, FISH probe counting, flow cytometry marker count billing, anti-markup rule compliance for referred testing, and PAMA pricing compliance for clinical laboratory Medicare billing. A general billing service applies standard lab billing to pathology — that approach misses IHC add-on stains, undercodes surgical pathology levels, and applies Tier 2 molecular codes when Tier 1 codes exist.

Find Out What Your Pathology Practice Should Be Collecting Per Specimen

The free pathology billing audit reviews your TC/26 modifier accuracy, surgical pathology level coding, IHC stain count billing, molecular pathology tier assignment, specimen count accuracy, and denial patterns — and shows you in plain numbers what every specimen should be generating versus what it actually is.

Get My Free Pathology Billing Audit

📞 +1 (307) 443-6706

✉️ info@netixmedicalbilling.com